Literature DB >> 2785715

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.

M Hatakeyama1, M Tsudo, S Minamoto, T Kono, T Doi, T Miyata, M Miyasaka, T Taniguchi.   

Abstract

Interleukin-2 (IL-2) binds to two distinct receptor molecules, the IL-2 receptor alpha (IL-2R alpha, p55) chain and the newly identified IL-2 receptor beta (IL-2R beta, p70-75) chain. The cDNA encoding the human IL-2R beta chain has now been isolated. The overall primary structure of the IL-2R beta chain shows no apparent homology to other known receptors. Unlike the IL-2R alpha chain, the IL-2R beta chain has a large cytoplasmic region in which a functional domain (or domains) mediating an intracellular signal transduction pathway (or pathways) may be embodied. The cDNA-encoded beta chain binds and internalizes IL-2 when expressed on T lymphoid cells but not fibroblast cells. Furthermore, the cDNA gives rise to the generation of high-affinity IL-2 receptor when co-expressed with the IL-2R alpha chain cDNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785715     DOI: 10.1126/science.2785715

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  162 in total

1.  Improvement in the antibody productivity of human-human hybridomas by transfection with Tac gene.

Authors:  K Iwamoto; Y Shintani; R Sasada; T Honjo; K Kitano
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

2.  A simple and efficient mammalian gene expression system using an EBV-based vector transfected by electroporation in G2/M phase.

Authors:  K Teshigawara; Y Katsura
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

3.  Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands.

Authors:  G X Xie; A Miyajima; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 4.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

5.  Identification of multiple cis-elements and trans-acting factors involved in the induced expression of human IL-2 gene.

Authors:  H Shibuya; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

6.  Interleukin 2 regulates Raf-1 kinase activity through a tyrosine phosphorylation-dependent mechanism in a T-cell line.

Authors:  B C Turner; N K Tonks; U R Rapp; J C Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways.

Authors:  H Asao; T Takeshita; N Ishii; S Kumaki; M Nakamura; K Sugamura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Interferon-alpha and interleukin 2 synergistically enhance basic fibroblast growth factor synthesis and induce release, promoting endothelial cell growth.

Authors:  F Cozzolino; M Torcia; M Lucibello; L Morbidelli; M Ziche; J Platt; S Fabiani; J Brett; D Stern
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

9.  Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Authors:  S D Voss; T P Leary; P M Sondel; R J Robb
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming.

Authors:  Michal Marzec; Krzysztof Halasa; Xiaobin Liu; Hong Y Wang; Mangeng Cheng; Donald Baldwin; John W Tobias; Stephen J Schuster; Anders Woetmann; Qian Zhang; Suzanne D Turner; Niels Ødum; Mariusz A Wasik
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.